Clinical, Serologic, and Histologic Features of Gluten Sensitivity in Children - 20/02/14
, Fernanda Cristofori, MD 1, Stefania Castellaneta, MD 2, Carlo Polloni, MD 3, Veronica Albano, MD 4, Stefania Dellatte 5, Flavia Indrio, MD 1, Luciano Cavallo, MD 1, Carlo Catassi, MD, PhD 4Abstract |
Objective |
To describe the clinical, serologic, and histologic characteristics of children with gluten sensitivity (GS).
Study design |
We studied 15 children (10 males and 5 females; mean age, 9.6 ± 3.9 years) with GS who were diagnosed based on a clear-cut relationship between wheat consumption and development of symptoms, after excluding celiac disease (CD) and wheat allergy, along with 15 children with active CD (5 males and 10 females; mean age, 9.1 ± 3.1 years) and 15 controls with a functional gastrointestinal disorder (6 males and 9 females; mean age, 8.6 ± 2.7 years). All children underwent CD panel testing (native antigliadin antibodies IgG and IgA, anti-tissue transglutaminase antibody IgA and IgG, and anti-endomysial antibody IgA), hematologic assessment (hemoglobin, iron, ferritin, aspartate aminotransferase, erythrocyte sedimentation rate), HLA typing, and small intestinal biopsy (on a voluntary basis in the children with GS).
Results |
Abdominal pain was the most prevalent symptom in the children with GS (80%), followed by chronic diarrhea in (73%), tiredness (33%), bloating (26%), limb pain, vomiting, constipation, headache (20%), and failure to thrive (13%). Native antigliadin antibodies IgG was positive in 66% of the children with GS. No differences in nutritional, biochemical, or inflammatory markers were found between the children with GS and controls. HLA-DQ2 was found in 7 children with GS. Histology revealed normal to mildly inflamed mucosa (Marsh stage 0-1) in the children with GS.
Conclusion |
Our findings support the existence of GS in children across all ages with clinical, serologic, genetic, and histologic features similar to those of adults.
Le texte complet de cet article est disponible en PDF.Keyword : AGA, APT, CD, EMA, GFD, GS, IEL, SPT, tTG, WA
Plan
| C.C. has received consulting fees from Menarini Diagnostics, Schär, and Heinz Italia. The remaining authors declare no conflicts of interest. |
Vol 164 - N° 3
P. 463 - mars 2014 Retour au numéro
Article précédent
- VACTERL (Vertebral Defects, Anal Atresia, Tracheoesophageal Fistula with Esophageal Atresia, Cardiac Defects, Renal and Limb Anomalies) Association: Disease Spectrum in 25 Patients Ascertained for Their Upper Limb Involvement
- Diana Carli, Lorenzo Garagnani, Mario Lando, Tracy Fairplay, Sergio Bernasconi, Antonio Landi, Antonio Percesepe
- Biomarkers for Severity of Neonatal Hypoxic-Ischemic Encephalopathy and Outcomes in Newborns Receiving Hypothermia Therapy
- Lina F. Chalak, Pablo J. Sánchez, Beverley Adams-Huet, Abbot R. Laptook, Roy J. Heyne, Charles R. Rosenfeld
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?